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To the Editor: Zika virus (ZIKV), a mosquito-borne 
flavivirus, causes Zika fever, a self-limiting febrile and 
exanthematic arthralgia syndrome closely resembling 
dengue fever. Most often, signs and symptoms are macu-
lopapular rash, fever, arthralgia, myalgia, headache, and 
conjunctivitis; edema, sore throat, cough, and vomiting 
occur less frequently (1). The virus, which was initially 
isolated from a rhesus monkey (Macaca mulatta) in 1947 
in Uganda, has come to attention recently after a large 
outbreak occurred in the western Pacific region, including 
French Polynesia, New Caledonia, Easter Island, and the 
Cook Islands (2). Travel-related imported infections have 
thus been increasingly reported from the western Pacific 
and sporadically also in travelers to other regions of the 
world, including Thailand, Indonesia, and Senegal (2,3). 
ZIKV is transmitted by different Aedes mosquito species, 
and nonhuman primates play a role as reservoirs (1). After 
the beginning of the ZIKV epidemic in late 2013, a 20-fold 
increase of Guillain-Barré syndrome incidence was noted 
in French Polynesia; 1 patient was infected a week before 
neurologic symptoms started (4). We report an acute ZIKV 
infection in a traveler returning from Malaysian Borneo 
who experienced bilateral hearing difficulties during the 
course of illness.
On September 1, 2014, a 45-year-old woman was seen 
in an outpatient clinic in Heidelberg, Germany for fever of 
up to 39°C and maculopapular rash covering her trunk, arms, 
and legs. Fever had started on August 30, which was 6 days 
after she had returned from a 3-week vacation to peninsular 
Malaysia and Sabah, Malaysian Borneo. Laboratory analy-
ses showed a slightly elevated C-reactive protein level of 
5.2 mg/L (reference range <5.0), but liver function test and 
complete blood count results were within reference range. 
During the next 3 days, the fever subsided, but the patient 
experienced a sore throat, bilateral conjunctivitis, and a 
burning sensation of the palms and soles. These symptoms 
were accompanied by swelling of the hands and increasing 
arthralgia of the wrists, palms, and fingers. There was no 
lymphadenopathy. An indirect immunofluorescence assay 
for ZIKV (3) demonstrated an IgM titer of 1:640 and an IgG 
titer of 1:320 (cutoff <1:20) on day 6 of illness (Figure). An 
indirect immunofluorescence assay for dengue virus demon-
strated an IgG titer of 1:80 and no IgM (cutoff <1:20). 
Two days later, the patient experienced sudden bilater-
al dull and metallic hearing; in her left ear, she experienced 
a very short delay between a sound and her perception of 
the sound. Follow-up ZIKV serologic testing on day 11 of 
illness showed a decreased IgM titer of 1:160 and an in-
creased IgG titer of 1:2,560 (Figure). Viral neutralization 
testing (3) of the same sample demonstrated the presence of 
ZIKV-specific neutralizing antibodies. Chikungunya virus 
serology results were negative. An archived serum sam-
ple from day 3 of illness studied by ZIKV serology and a 
ZIKV-specific real-time reverse transcription PCR (3) was 
negative (Figure). Hearing difficulties lasted for 10 days 




During her journey to several cities and villages in 
Sabah, Malaysian Borneo, the patient had noticed several 
mosquito bites even though she had used repellents. She had 
stayed in hotels, private homes, and remote church homes 
under various conditions (online Technical Appendix, http://
wwwnc.cdc.gov/EID/article/21/5/14-1960-Techapp1.pdf).
In Asia, Zika fever has been described sporadically in 
Cambodia, Thailand, and Indonesia (Java and Lombok) 
(1,3,5,6). On the basis of the incubation time of ≈6 days 
in returning travelers (2,3), we assumed that the patient 
became infected in Keningau or surrounding villages, in 
northern Borneo. Although ZIKV was detected in Ae. ae-
gypti mosquitoes in peninsular Malaysia in 1969 (7) and 
antibodies against ZIKV were demonstrated in serum sam-
ples from 15 of 79 patients on peninsular Malaysia and 9 
of 50 patients in Borneo in 1953 (8), Zika fever in penin-
sular Malaysia or Borneo has not been reported. In 2001, 
ZIKV seropositivity was demonstrated in a native Bornean, 
2 migrants to Borneo, and 2 Bornean orangutans (Pongo 
pygmaeus) (9). A later study found an additional 8 Bornean 
orangutans to be seropositive for antibodies against ZIKV 
(10). Thus, in Borneo, either the virus only rarely infects 
humans or the disease is mistaken for dengue fever. 
Neurologic complications of ZIKV infections had pre-
viously been reported only as Guillain-Barré syndrome, 
and hearing difficulties in Zika fever patients have not been 
reported. Because this symptom resolved spontaneously, 
no audiometry or auditory brainstem response testing was 
performed, and the cause of the disorder remains unclear. 
Because of increasing travel and migration and heightened 
clinical and laboratory awareness, more ZIKV infections 
are likely to be diagnosed outside of epidemic events.
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To the Editor: Providing medical care for Ebola vi-
rus–infected patients entails physical and psychological 
stress, extended shift times, and risk for infection. In addi-
tion, the wearing of personal protective equipment impairs 
communication and performance of diagnostic and thera-
peutic procedures. Lessons learned from outbreaks of other 
infectious diseases indicate that such challenging treatment 
environments require the monitoring of health care profes-
sionals for psychological distress (e.g., anxiety, depression, 
fatigue, and social isolation) to prevent personal exhaustion 
and reduced job performance (1). 
In August 2014, the first patient in Germany known 
to have Ebola virus disease was admitted to the Univer-
sity Medical Center Hamburg-Eppendorf (2) and received 
treatment in the isolation facility for 18 days. We hypothe-
sized that health care professionals working in the isolation 
unit who had direct contact with the Ebola patient would 
show more signs of psychological distress than those not 
working in the isolation unit.
To test our hypothesis, we conducted a cross-sectional 
controlled study by using validated self-report scales (1,3–
5) and open-response questions. Seven days after the Ebola 
patient was admitted, we distributed questionnaires to the 
46 health care professionals (17 physicians, 29 nurses) who 
had direct contact with the patient (Table). 
Of the 46 health care professionals, 30 participated in 
the study. During patient contact, these staff members wore 
Astro-Protect pressurized suits (Asatex, Bergheim, Germa-
ny). As a control group, 40 health care professionals from 
other wards in the same department were recruited and par-
ticipated in the study. Providers in the control group cared 
for terminally ill patients and for patients with reduced con-
sciousness, but they had no direct contact with the Ebola 
patient. The control participants were not recruited from 
intensive care units because, at the time of the study, the 
patient was not receiving intensive care treatment. The 2 
groups were balanced with respect to age and occupational 
characteristics (Table). There was no special psychologi-
cal support service for health care workers in this hospital. 
Staff members had received mandatory biweekly training, 
which included decontamination procedures, technical as-
pects of diagnostic procedures, and emergency care.
In contrast to our hypothesis, no significant differences 
emerged between the 2 groups with respect to the sever-
ity of somatic symptoms, anxiety, depression, and fatigue 
(Table). Moreover, mean total scores for both groups were 
at a comparable level to mean scores for the general popu-
lation (3–5). However, health care professionals who had 
direct contact with the Ebola patient reported significantly 
greater social isolation and felt significantly more need for 
shorter shift hours. The open responses of participants who 
experienced social isolation suggested that their spouses, 
children, and other relatives had infection-related concerns. 
Additionally, half of the participants who did not have di-
rect patient contact reported feeling a need for psychologi-
cal preparation (Table). Nevertheless, almost all health care 
professionals (97% of those with direct patient contact, 
93% of those without direct patient contact) believed that 
the health care facilities of the hospital were safe. 
Our investigation of the psychological stress of health 
care professionals in a Western tertiary care center showed 
that a well-trained and dedicated team can cope well with 
the stress of caring for a severely ill Ebola patient. Of note, 
the direct patient contact group tended to comprise more 
male participants and more participants living with part-
ners, which may have influenced the experience of psycho-
logical stress. No staff member refused to participate in the 
treatment of the Ebola patient, which underlines the high 
level of motivation within the team and may render direct 
comparison to other centers difficult. 
While the patient was in the isolation unit, working 
shifts lasted up to 12 hours, consisting of 2 periods with 3–4 
hours of work while wearing personal protective equipment 
in addition to time spent disinfecting. Most respondents felt 
that these shifts were too long. We therefore suggest that 
shift durations should be decreased to 8 hours comprising 
2 blocks of 2 hours each for direct patient contact. Shorter 
shifts should improve staff satisfaction with the working 
conditions and potentially increase the personal safety of 
all health care personnel involved in direct patient contact.
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	21,	No.	5,	May	2015	 913
LETTERS
1These	authors	contributed	equally	to	this	article.
